NPPS knockdown with siRNAs in lung cancer, pancreatic cancer and colorectal cancer cell lines selectively suppressed the viability and growth of RAS-mutant cells (Fig. 1d, e, S2b–d). This evidence concerns the gene ENPP1 and lung carcinoma.